BMN 270-401
Research payments
$595,313
Through program year 2025, $595,313 in research payments was reported against BMN 270-401, across 160 payments, paid by BioMarin Pharmaceutical Inc..
- Paid by
- BioMarin Pharmaceutical Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $312,952 | 94 |
| 2024 | Research | $282,361 | 66 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Elaine Majerus Saint Louis, MO Named on 22 payments
- Andrew Leavitt San Francisco, CA Named on 15 payments
- Erin Cockrell Tampa, FL Named on 13 payments
- Adam Giermasz Sacramento, CA Named on 10 payments
- Steven Pipe Ann Arbor, MI Named on 9 payments
- Nigel Key Chapel Hill, NC Named on 9 payments
- Michael Wang Aurora, CO Named on 8 payments
- Vivek Sharma Louisville, KY Named on 7 payments
- Doris Quon Los Angeles, CA Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.